|
|
|
9 of 9 H1N1 Flu Shots / Flu Mist |
|
|
|
 |
| MedImmune Influenza A H1N1 2009 Monovalent Vaccine Live, Intranasal
|
|
|
Mercury Levels: | No mercury
| |
Recipient's Age: | 2 years to 49 years
| |
H1N1 Flu Shot or Mist: | mist
| |
Manufacturer: | MedImmune
| |
|
|
|
|
|
|
|
|
 |
Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal is indicated for the active immunization of individuals 2-49 years of age against influenza disease caused by pandemic (H1N1) 2009 virus.
Dosage and Administration
Based on currently available information the vaccination regimen is as follows:
Children (2-9 years) - 2 doses (0.2 mL each, approximately 1 month apart)
Children, adolescents and adults (10-49 years) - 1 dose (0.1 mL)
Dosage and Strength
Prefilled single-dose intranasal sprayer containing 0.2 mL suspension.
Contraindications
- Hypersensitivity to eggs, egg proteins, gentamicin, gelatin or arginine or life threatening reactions to previous influenza vaccination.
- Concomitant aspirin therapy in children and adolescents.
Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal should not be administered to any individuals with asthma or children < 5 years of age with recurrent wheezing because of the potential for increased risk of wheezing post vaccination.
- If Guillain-Barre syndrome has occurred with any prior influenza vaccination, the decision to give Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal should be based on careful consideration of the potential benefits and risks.
- Administration of Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal, a live virus vaccine, to immunocompromised persons should be based on careful consideration of potential benefits and risks.
- Safety has not been established in individuals with underlying medical conditions predisposing them to wild-type influenza infection complications.
Adverse Reactions
ADVERSE REACTIONS information is based on studies conducted with seasonal trivalent Influenza Vaccine Live, Intranasal (FluMist) manufactured by MedImmune.
Most common adverse reactions (≥ 10% in FluMist and at least 5% greater than in control) are runny nose or nasal congestion in all ages, fever >100°F in children 2-6 years of age, and sore throat in adults.
To report SUSPECTED ADVERSE REACTIONS, contact MedImmune at 1-877-633-4411 or VAERS at 1-800-822-7967 or http://vaers.hhs.
Drug Interactions
Antiviral agents active against influenza A and/or B: Do not administer Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal until 48 hours after antiviral cessation. Antiviral agents should not be administered until 2 weeks after Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal administration unless medically necessary.
Use In Specific Populations
Safety and effectiveness of Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal have not been studied in pregnant women or nursing mothers.
|
|
Dosage Information:
Prefilled single-dose intranasal sprayer containing 0.2 mL suspension.
|
Pregnanct Safe:
Consult your physician
|
|
|
|
|
